{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T05:03:06Z","timestamp":1794891786620,"version":"4.9.1"},"reference-count":259,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T00:00:00Z","timestamp":1635292800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Opioids are widely used as therapeutic agents against moderate to severe acute and chronic pain. Still, these classes of analgesic drugs have many potential limitations as they induce analgesic tolerance, addiction and numerous behavioural adverse effects that often result in patient non-compliance. As opium and opioids have been traditionally used as painkillers, the exact mechanisms of their adverse reactions over repeated use are multifactorial and not fully understood. Older adults suffer from cancer and non-cancer chronic pain more than younger adults, due to the physiological changes related to ageing and their reduced metabolic capabilities and thus show an increased number of adverse reactions to opioid drugs. All clinically used opioids are \u03bc-opioid receptor agonists, and the major adverse effects are directly or potentially connected to this receptor. Multifunctional opioid ligands or peripherally restricted opioids may elicit fewer adverse effects, as shown in preclinical studies, but these results need reproducibility from further extensive clinical trials. The current review aims to overview various mechanisms involved in the adverse effects induced by opioids, to provide a better understanding of the underlying pathophysiology and, ultimately, to help develop an effective therapeutic strategy to better manage pain.<\/jats:p>","DOI":"10.3390\/ph14111091","type":"journal-article","created":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T23:24:42Z","timestamp":1635377082000},"page":"1091","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":305,"title":["Opioid Analgesia and Opioid-Induced Adverse Effects: A Review"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6090-2407","authenticated-orcid":false,"given":"Alok K.","family":"Paul","sequence":"first","affiliation":[{"name":"School of Pharmacy and Pharmacology, University of Tasmania, Hobart, TAS 7001, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig M.","family":"Smith","sequence":"additional","affiliation":[{"name":"School of Medicine, Institute for Mental and Physical Health and Clinical Translation, Deakin University, Geelong, VIC 3216, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Rahmatullah","sequence":"additional","affiliation":[{"name":"Department of Biotechnology & Genetic Engineering, University of Development Alternative, Dhanmondi, Dhaka 1207, Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veeranoot","family":"Nissapatorn","sequence":"additional","affiliation":[{"name":"School of Allied Health Sciences, World Union for Herbal Drug Discovery (WUHeDD) and Research Excellence Center for Innovation and Health Products (RECIHP), Walailak University, Nakhon Si Thammarat 80160, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2730-7788","authenticated-orcid":false,"given":"Polrat","family":"Wilairatana","sequence":"additional","affiliation":[{"name":"Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok 10400, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2379-5358","authenticated-orcid":false,"given":"Mariana","family":"Spetea","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Institute of Pharmacy and Center for Molecular Biosciences (CMBI), University of Innsbruck, Innrain 80\u201382, 6020 Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3782-767X","authenticated-orcid":false,"given":"Nuri","family":"Gueven","sequence":"additional","affiliation":[{"name":"School of Pharmacy and Pharmacology, University of Tasmania, Hobart, TAS 7001, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolas","family":"Dietis","sequence":"additional","affiliation":[{"name":"Medical School, University of Cyprus, Nicosia 1678, Cyprus"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,10,27]]},"reference":[{"key":"ref_1","unstructured":"IASP (2021, October 26). Pain, IASP Terminology. International Association for the Study of Pain (IASP). Available online: https:\/\/www.iasp-pain.org\/resources\/terminology\/#pain."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0304-3959(98)00099-2","article-title":"Towards a mechanism-based classification of pain?","volume":"77","author":"Woolf","year":"1998","journal-title":"Pain"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1016\/S0140-6736(99)01307-0","article-title":"Neuropathic pain: Aetiology, symptoms, mechanisms, and management","volume":"353","author":"Woolf","year":"1999","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1016\/S0140-6736(21)00392-5","article-title":"Nociplastic pain: Towards an understanding of prevalent pain conditions","volume":"397","author":"Fitzcharles","year":"2021","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Nijs, J., Lahousse, A., Kapreli, E., Bilika, P., Sara\u00e7o\u011flu, I., Malfliet, A., Coppieters, I., De Baets, L., Leysen, L., and Roose, E. (2021). Nociplastic pain criteria or recognition of central sensitization? Pain phenotyping in the past, present and future. J. Clin. Med., 10.","DOI":"10.3390\/jcm10153203"},{"key":"ref_6","unstructured":"IASP (2021, August 25). Central Sensitization, IASP Terminology. Available online: https:\/\/www.iasp-pain.org\/resources\/terminology\/?navItemNumber=576#Centralsensitization."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s12017-012-8180-3","article-title":"Opioid system and Alzheimer\u2019s disease","volume":"14","author":"Cai","year":"2012","journal-title":"Neuromol. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1016\/S0304-3959(99)00145-1","article-title":"From the gate to the neuromatrix","volume":"82","author":"Melzack","year":"1999","journal-title":"Pain"},{"key":"ref_9","first-page":"291","article-title":"The endogenous opioid system and clinical pain management","volume":"16","author":"Holden","year":"2005","journal-title":"AACN Clin. Issues Adv. Pr. Acute Crit. Care"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1152\/physrev.00005.2009","article-title":"Reward processing by the opioid system in the brain","volume":"89","author":"Becker","year":"2009","journal-title":"Physiol. Rev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/j.2042-7158.1954.tb11033.x","article-title":"Synthetic analgesics: Stereochemical considerations","volume":"6","author":"Beckett","year":"2011","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_12","first-page":"517","article-title":"The effects of morphine-and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog","volume":"197","author":"Martin","year":"1976","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_13","unstructured":"Borsodi, A., Bruchas, M., Cal\u00f3, G., Chavkin, C., Christie, M.J., Civelli, O., Connor, M., Cox, B.M., Devi, L.A., and Evans, C. (2021, October 26). Opioid Receptors, Introduction. IUPHAR\/BPS Guide to PHARMACOLOGY. Available online: http:\/\/www.guidetoimmunopharmacology.org\/GRAC\/FamilyIntroductionForward?familyId=50."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1111\/bph.12445","article-title":"The concise guide to PHARMACOLOGY 2013\/14: G Protein-Coupled receptors","volume":"170","author":"Alexander","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1146\/annurev.biochem.73.011303.073940","article-title":"Opioid receptors","volume":"73","author":"Waldhoer","year":"2004","journal-title":"Annu. Rev. Biochem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1042\/bj2950625","article-title":"Molecular cloning of a rat kappa opioid receptor reveals sequence similarities to the mu and delta opioid receptors","volume":"295","author":"Chen","year":"1993","journal-title":"Biochem. J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0014-5793(94)80235-1","article-title":"ORL1, a novel member of the opioid receptor family","volume":"341","author":"Mollereau","year":"1994","journal-title":"FEBS Lett."},{"key":"ref_18","first-page":"400","article-title":"Structure of the \u03b4-opioid receptor bound to naltrindole","volume":"485","author":"Granier","year":"2012","journal-title":"Nat. Cell Biol."},{"key":"ref_19","first-page":"314","article-title":"How opioid drugs bind to receptors","volume":"485","author":"Filizola","year":"2012","journal-title":"Nat. Cell Biol."},{"key":"ref_20","first-page":"321","article-title":"Crystal structure of the \u00b5-opioid receptor bound to a morphinan antagonist","volume":"485","author":"Manglik","year":"2012","journal-title":"Nat. Cell Biol."},{"key":"ref_21","first-page":"395","article-title":"Structure of the nociceptin\/orphanin FQ receptor in complex with a peptide mimetic","volume":"485","author":"Thompson","year":"2012","journal-title":"Nat. Cell Biol."},{"key":"ref_22","first-page":"327","article-title":"Structure of the human \u03ba-opioid receptor in complex with JDTic","volume":"485","author":"Wu","year":"2012","journal-title":"Nat. Cell Biol."},{"key":"ref_23","first-page":"819","article-title":"Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the \u00b5-opioid-receptor gene","volume":"383","author":"Matthes","year":"1996","journal-title":"Nat. Cell Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0165-6147(98)01279-6","article-title":"Opioids: First lessons from knockout mice","volume":"20","author":"Kieffer","year":"1999","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1073\/pnas.94.4.1544","article-title":"Opiate receptor knockout mice define mu receptor roles in endogenous nociceptive responses and morphine-induced analgesia","volume":"94","author":"Sora","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"S153","DOI":"10.1038\/sj.bjp.0706435","article-title":"75 years of opioid research: The exciting but vain quest for the Holy Grail","volume":"147","author":"Corbett","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1124\/pr.112.005942","article-title":"Regulation of \u00b5-opioid receptors: Desensitization, phosphorylation, internalization, and tolerance","volume":"65","author":"Williams","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.3389\/fphar.2018.01388","article-title":"Advances in achieving opioid analgesia without side effects","volume":"9","author":"Machelska","year":"2018","journal-title":"Front. Pharmacol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41583-018-0028-x","article-title":"Opioid receptors: Drivers to addiction?","volume":"19","author":"Darcq","year":"2018","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1093\/bja\/aeg279","article-title":"Comparison of morphine-6-glucuronide and morphine on respiratory depressant and antinociceptive responses in wild type and mu-opioid receptor deficient mice","volume":"91","author":"Romberg","year":"2003","journal-title":"Br. J. Anaesth."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1124\/jpet.113.204313","article-title":"Mechanisms that underlie \u03bc-opioid receptor agonist\u2013induced constipation: Differential involvement of \u03bc-opioid receptor sites and responsible regions","volume":"347","author":"Mori","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"19208","DOI":"10.1073\/pnas.0506627102","article-title":"Opioid-induced tolerance and dependence in mice is modulated by the distance between pharmacophores in a bivalent ligand series","volume":"102","author":"Daniels","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"16459","DOI":"10.1523\/JNEUROSCI.3748-10.2010","article-title":"Ligand-directed trafficking of the-opioid receptor in vivo: Two paths toward analgesic tolerance","volume":"30","author":"Pradhan","year":"2010","journal-title":"J. Neurosci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1038\/sj.bjp.0703248","article-title":"Antihyperalgesic effects of \u03b4 opioid agonists in a rat model of chronic inflammation","volume":"129","author":"Fraser","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0304-3959(02)00333-0","article-title":"Up-regulation and trafficking of delta opioid receptor in a model of chronic inflammation: Implications for pain control","volume":"101","author":"Cahill","year":"2003","journal-title":"Pain"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.pain.2010.12.031","article-title":"Genetic ablation of delta opioid receptors in nociceptive sensory neurons increases chronic pain and abolishes opioid analgesia","volume":"152","author":"Nozaki","year":"2011","journal-title":"Pain"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.pain.2006.08.003","article-title":"Anti-Allodynic effects of peripheral delta opioid receptors in neuropathic pain","volume":"127","author":"Kabli","year":"2007","journal-title":"Pain"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.pain.2006.01.032","article-title":"Cancer-related bone pain is attenuated by a systemically available \u03b4-opioid receptor agonist","volume":"122","author":"Smith","year":"2006","journal-title":"Pain"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1097\/AJP.0b013e3181c49e3a","article-title":"Delta and kappa opioid receptors as suitable drug targets for pain","volume":"26","author":"Vanderah","year":"2010","journal-title":"Clin. J. Pain"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/bph.12706","article-title":"Recent advances on the \u03b4 opioid receptor: From trafficking to function","volume":"172","author":"Gendron","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"ref_41","first-page":"875","article-title":"A novel delta opioid agonist, BW373U86, in squirrel monkeys responding under a schedule of shock titration","volume":"267","author":"Dykstra","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_42","first-page":"1025","article-title":"Behavioral effects of the systemically active delta opioid agonist BW373U86 in rhesus monkeys","volume":"270","author":"Negus","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_43","first-page":"362","article-title":"Behavioral effects of the delta-selective opioid agonist SNC80 and related compounds in rhesus monkeys","volume":"286","author":"Negus","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1124\/jpet.111.188987","article-title":"\u03b4-Opioid mechanisms for ADL5747 and ADL5859 effects in mice: Analgesia, locomotion, and receptor internalization","volume":"342","author":"Nozaki","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1124\/jpet.102.036525","article-title":"Comparison of receptor mechanisms and efficacy requirements for \u03b4-agonist-induced convulsive activity and antinociception in mice","volume":"303","author":"Broom","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0304-3959(02)00259-2","article-title":"Analgesia from a peripherally active \u03ba-opioid receptor agonist in patients with chronic pancreatitis","volume":"101","author":"Eisenach","year":"2003","journal-title":"Pain"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1038\/sj.bjp.0705763","article-title":"Peripheral kappa-opioid agonists for visceral pain","volume":"141","author":"Riviere","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.brainres.2016.06.048","article-title":"The contribution of activated peripheral kappa opioid receptors (kORs) in the inflamed knee joint to anti-nociception","volume":"1648","author":"Moon","year":"2016","journal-title":"Brain Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/sj.bjp.0703782","article-title":"Contralateral but not systemic administration of the \u03ba-opioid agonist U-50,488H induces anti-nociception in acute hindpaw inflammation in rats","volume":"132","author":"Spetea","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0014-2999(95)00122-2","article-title":"Antinociceptive effect of a kappa-opioid receptor agonist that minimally crosses the blood-brain barrier (ICI 204448) in a rat model of mononeuropathy","volume":"277","author":"Keita","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ejphar.2004.04.043","article-title":"Contralateral, ipsilateral and bilateral treatments with the \u03ba-opioid receptor agonist U-50,488H in mononeuropathic rats","volume":"494","author":"Spetea","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"ref_52","first-page":"413","article-title":"Kappa opioids in rhesus monkeys. I. Diuresis, sedation, analgesia and discriminative stimulus effects","volume":"242","author":"Dykstra","year":"1987","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s002130051144","article-title":"Effects of E-2078, a stable dynorphin A(1-8) analog, on sedation and serum prolactin levels in rhesus monkeys","volume":"147","author":"Butelman","year":"1999","journal-title":"Psychopharmacology"},{"key":"ref_54","first-page":"1113","article-title":"Intracisternal nor-binaltorphimine distinguishes central and peripheral kappa-opioid antinociception in rhesus monkeys","volume":"291","author":"Ko","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2174\/156802607779941251","article-title":"Kappa receptor bivalent ligands","volume":"7","author":"Peng","year":"2007","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_56","first-page":"178","article-title":"UFP-112 a potent and long-lasting agonist selective for the nociceptin\/orphanin FQ receptor","volume":"17","author":"Rizzi","year":"2010","journal-title":"CNS Neurosci. Ther."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.peptides.2007.04.020","article-title":"In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin\/orphanin FQ receptor","volume":"28","author":"Rizzi","year":"2007","journal-title":"Peptides"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.pain.2009.10.026","article-title":"Long-lasting antinociceptive spinal effects in primates of the novel nociceptin\/orphanin FQ receptor agonist UFP-112","volume":"148","author":"Hu","year":"2010","journal-title":"Pain"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1038\/npp.2009.33","article-title":"Behavioral effects of a synthetic agonist selective for nociceptin\/orphanin FQ peptide receptors in monkeys","volume":"34","author":"Ko","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1124\/jpet.108.136937","article-title":"The anxiolytic-like effects of the novel, orally active nociceptin opioid receptor agonist 8-[bis(2-methylphenyl)methyl]-3-phenyl-8-azabicyclo[3.2.1]octan-3-ol (SCH 221510)","volume":"326","author":"Varty","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1021\/cn300124f","article-title":"The therapeutic potential of nociceptin\/orphanin FQ receptor agonists as analgesics without abuse liability","volume":"4","author":"Lin","year":"2012","journal-title":"ACS Chem. Neurosci."},{"key":"ref_62","first-page":"812","article-title":"Pharmacological characterization of the novel nonpeptide orphanin FQ\/nociceptin receptor agonist Ro 64-6198: Rapid and reversible desensitization of the ORL1 receptor in vitro and lack of tolerance in vivo","volume":"298","author":"Dautzenberg","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ejphar.2007.10.031","article-title":"Effects of nociceptin\/orphanin FQ receptor (NOP) agonist, Ro64-6198, on reactivity to acute pain in mice: Comparison to morphine","volume":"579","author":"Reiss","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pain.2005.03.012","article-title":"Spinal and local peripheral antiallodynic activity of Ro64-6198 in neuropathic pain in the rat","volume":"116","author":"Obara","year":"2005","journal-title":"Pain"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/2049463712438493","article-title":"Basic opioid pharmacology: An update","volume":"6","author":"Pathan","year":"2012","journal-title":"Br. J. Pain"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/5706","article-title":"Retention of heroin and morphine\u20136\u03b2\u2013glucuronide analgesia in a new line of mice lacking exon 1 of MOR\u20131","volume":"2","author":"Schuller","year":"1999","journal-title":"Nat. Neurosci."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0169-328X(97)00353-7","article-title":"mu Opioid receptor knockout in mice: Effects on ligand-induced analgesia and morphine lethality","volume":"54","author":"Loh","year":"1998","journal-title":"Brain Res. Mol. Brain Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0896-6273(00)80836-3","article-title":"Retention of supraspinal delta-like analgesia and loss of morphine tolerance in \u03b4 opioid receptor knockout mice","volume":"24","author":"Zhu","year":"1999","journal-title":"Neuron"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1093\/emboj\/17.4.886","article-title":"Disruption of the kappa-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective kappa-agonist U-50,488H and attenuates morphine withdrawal","volume":"17","author":"Simonin","year":"1998","journal-title":"EMBO J."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"7285","DOI":"10.1523\/JNEUROSCI.18-18-07285.1998","article-title":"Activity of the delta-opioid receptor is partially reduced, whereas activity of the kappa-receptor is maintained in mice lacking the mu-receptor","volume":"18","author":"Matthes","year":"1998","journal-title":"J. Neurosci."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0014-2999(99)00897-3","article-title":"Delta-opioid receptor agonists produce antinociception and [35S]GTPgammaS binding in mu receptor knockout mice","volume":"388","author":"Hosohata","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Van Miert, A.S.J.P.A.M., Bogaert, M.G., and Debackere, M. (1986). Opioid peptides and their receptors. Comparative Veterinary Pharmacology, Toxicology and Theraphy, Springer.","DOI":"10.1007\/978-94-009-4153-3"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1002\/jor.20132","article-title":"Opioid peptides and receptors in joint tissues: Study in the rat","volume":"24","author":"Ahmed","year":"2006","journal-title":"J. Orthop. Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/0888-6296(87)90046-9","article-title":"Opiates, opioid peptides, and their receptors","volume":"1","author":"Callahan","year":"1987","journal-title":"J. Cardiothorac. Anesth."},{"key":"ref_75","first-page":"5","article-title":"Opioid peptides, opioid receptors and mechanism of down regulation","volume":"41","author":"Chaturvedi","year":"2003","journal-title":"Indian J. Exp. Boil."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1146\/annurev.ne.02.030179.000343","article-title":"Opiate receptors and opioid peptides","volume":"2","author":"Snyder","year":"1979","journal-title":"Annu. Rev. Neurosci."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s40620-014-0163-z","article-title":"Diagnostic and short-term prognostic utility of plasma pro-enkephalin (pro-ENK) for acute kidney injury in patients admitted with sepsis in the emergency department","volume":"28","author":"Marino","year":"2015","journal-title":"J. Nephrol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ygcen.2007.02.023","article-title":"Tracking the evolution of the proenkephalin gene in tetrapods","volume":"153","author":"Roberts","year":"2007","journal-title":"Gen. Comp. Endocrinol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0169-328X(03)00126-8","article-title":"Characterization of zebrafish proenkephalin reveals novel opioid sequences","volume":"114","author":"Rodriguez","year":"2003","journal-title":"Brain Res. Mol. Brain Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1471-4159.2006.03732.x","article-title":"Big dynorphin as a putative endogenous ligand for the kappa-opioid receptor","volume":"97","author":"Merg","year":"2006","journal-title":"J. Neurochem."},{"key":"ref_81","first-page":"397","article-title":"Dynorphins in regulation of immune system functions","volume":"79","author":"Gein","year":"2014","journal-title":"Biochemistry"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/0024-3205(89)90419-0","article-title":"Beta-endorphin and related peptides suppress phorbol myristate acetate-induced respiratory burst in human polymorphonuclear leukocytes","volume":"45","author":"Diamant","year":"1989","journal-title":"Life Sci."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1172\/JCI112501","article-title":"Pro-opiomelanocortin messenger ribonucleic acid and posttranslational processing of beta endorphin in spleen macrophages","volume":"77","author":"Lolait","year":"1986","journal-title":"J. Clin. Investig."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.peptides.2013.10.001","article-title":"Endogenous opiates and behavior: 2012","volume":"50","author":"Bodnar","year":"2013","journal-title":"Peptides"},{"key":"ref_85","unstructured":"Fine, P.G., and Portenoy, R.K. (2004). A Clinical Guide to Opioid Analgesia, The McGraw-Hill Companies."},{"key":"ref_86","unstructured":"(2017, October 22). AMH. Analgesics (Ch 3). In Australian Medicines Handbook (AMH). Available online: https:\/\/amhonline.amh.net.au\/chapters\/chap-03?menu=vertical."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1200\/JCO.2013.53.1079","article-title":"Opiate pharmacology and relief of pain","volume":"32","author":"Pasternak","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Pena, D.A., Duarte, M.L., Pramio, D.T., Devi, L.A., and Schechtman, D. (2018). Exploring morphine-triggered PKC-targets and their interaction with signaling pathways leading to pain via TrkA. Proteomes, 6.","DOI":"10.3390\/proteomes6040039"},{"key":"ref_89","unstructured":"Pasternak, G.W. (2011). Opioid receptor signal transduction mechanism. The Opiate Receptors, Humana Press. [2nd ed.]."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.brainres.2006.03.119","article-title":"Opioid \u03bc receptor activation inhibits sodium currents in prefrontal cortical neurons via a protein kinase A- and C-dependent mechanism","volume":"1094","author":"Witkowski","year":"2006","journal-title":"Brain Res."},{"key":"ref_91","first-page":"90","article-title":"Activation of \u00ce\u00bc-opioid receptors inhibits calcium-currents in the vestibular afferent neurons of the rat through a cAMP dependent mechanism","volume":"8","author":"Vega","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nrm3072","article-title":"CREB and the CRTC co-activators: Sensors for hormonal and metabolic signals","volume":"12","author":"Altarejos","year":"2011","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s12640-018-9905-3","article-title":"L-3-n-Butylphthalide regulates proliferation, migration, and differentiation of neural stem cell in vitro and promotes neurogenesis in APP\/PS1 mouse model by regulating BDNF\/TrkB\/CREB\/Akt pathway","volume":"34","author":"Lei","year":"2018","journal-title":"Neurotox. Res."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1158\/1541-7786.MCR-17-0576","article-title":"Targeting CREB Pathway Suppresses Small Cell Lung Cancer","volume":"16","author":"Xia","year":"2018","journal-title":"Mol. Cancer Res."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Smith, T.H., Grider, J.R., Dewey, W.L., and Akbarali, H.I. (2012). Morphine decreases enteric neuron excitability via inhibition of sodium channels. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0045251"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1744-8069-8-26","article-title":"Inhibition of Ca2+\/Calmodulin-Dependent protein kinase II reverses oxaliplatin-induced mechanical allodynia in rats","volume":"8","author":"Shirahama","year":"2012","journal-title":"Mol. Pain"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"4904","DOI":"10.1038\/s41598-018-23199-4","article-title":"Dual Role of CREB in the regulation of VSMC Proliferation: Mode of activation determines pro-or anti-mitogenic function","volume":"8","author":"Hudson","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"772","DOI":"10.2174\/092986708783955518","article-title":"The other side of the opioid story: Modulation of cell growth and survival signaling","volume":"15","author":"Chen","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Knapp, C.M. (2002). Opiates. Encyclopedia of the Human Brain, Academic Press.","DOI":"10.1016\/B0-12-227210-2\/00260-0"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"14611","DOI":"10.1038\/ncomms14611","article-title":"Endogenous opioids regulate moment-to-moment neuronal communication and excitability","volume":"8","author":"Winters","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_101","first-page":"219","article-title":"The pharmacological basis of opioids","volume":"12","author":"Ghelardini","year":"2015","journal-title":"Clin. Cases Miner. Bone Metab."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.neulet.2009.01.066","article-title":"\u03bc-Opioid receptor-independent fashion of the suppression of sodium currents by \u03bc-opioid analgesics in thalamic neurons","volume":"453","author":"Hashimoto","year":"2009","journal-title":"Neurosci. Lett."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1124\/mol.115.098848","article-title":"Biased agonism of endogenous opioid peptides at the \u03bc-Opioid receptor","volume":"88","author":"Thompson","year":"2015","journal-title":"Mol. Pharmacol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ceb.2013.10.008","article-title":"Recent developments in biased agonism","volume":"27","author":"Wisler","year":"2014","journal-title":"Curr. Opin. Cell Biol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3410\/B1-87","article-title":"Biased agonism","volume":"1","author":"Kenakin","year":"2009","journal-title":"F1000 Biol. Rep."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1021\/cn200111m","article-title":"A simple method for quantifying functional selectivity and agonist bias","volume":"3","author":"Kenakin","year":"2012","journal-title":"ACS Chem. Neurosci."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1097\/ALN.0b013e318238bba6","article-title":"Molecular mechanisms of opioid receptor-dependent signaling and behavior","volume":"115","author":"Bruchas","year":"2011","journal-title":"Anesthesiology"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"12522","DOI":"10.1074\/jbc.M109.059410","article-title":"Morphine-like opiates selectively antagonize receptor-arrestin interactions","volume":"285","author":"Molinari","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1126\/science.286.5449.2495","article-title":"Enhanced morphine analgesia in mice lacking beta-arrestin 2","volume":"286","author":"Bohn","year":"1999","journal-title":"Science"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/j.pain.2014.06.011","article-title":"Biased agonism of the \u03bc-opioid receptor by TRV130 increases analgesia and reduces on-target adverse effects versus morphine: A randomized, double-blind, placebo-controlled, crossover study in healthy volunteers","volume":"155","author":"Soergel","year":"2014","journal-title":"Pain"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1124\/jpet.112.201616","article-title":"A G Protein-Biased Ligand at the \u03bc-Opioid receptor is potently analgesic with reduced gastrointestinal and respiratory dysfunction compared with morphine","volume":"344","author":"DeWire","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1124\/jpet.105.087254","article-title":"Morphine Side Effects in \u03b2-Arrestin 2 Knockout Mice","volume":"314","author":"Raehal","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1124\/mol.106.028258","article-title":"An opioid agonist that does not induce \u03bc-Opioid receptor\u2014arrestin interactions or receptor internalization","volume":"71","author":"Groer","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ejphar.2012.04.001","article-title":"Differences in the characteristics of tolerance to \u03bc-opioid receptor agonists in the colon from wild type and \u03b2-arrestin2 knockout mice","volume":"685","author":"Maguma","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1111\/bph.13854","article-title":"Selective \u03ba receptor partial agonist HS666 produces potent antinociception without inducing aversion after i.c.v. administration in mice","volume":"174","author":"Spetea","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.neuropharm.2015.08.027","article-title":"Investigation of the role of \u03b2arrestin2 in kappa opioid receptor modulation in a mouse model of pruritus","volume":"99","author":"Morgenweck","year":"2015","journal-title":"Neuropharmacology"},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Jin, Z., Zhu, M., Gupta, A., Page, C., Gan, T.J., and Bergese, S.D. (2021). Evaluating oliceridine as a treatment option for moderate to severe acute post-operative pain in adults. Expert Opin. Pharmacother., 1\u20139.","DOI":"10.1080\/14656566.2021.1982893"},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Hammer, G.B., Khanna, A.K., Michalsky, C., Wase, L., Demitrack, M.A., Little, R., Fossler, M.J., and Ayad, S. (2021). Oliceridine exhibits improved tolerability compared to morphine at equianalgesic conditions: Exploratory analysis from two phase 3 randomized placebo and active controlled trials. Pain Ther., 1\u201311.","DOI":"10.1007\/s40122-021-00299-0"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1021\/acschemneuro.8b00150","article-title":"DARK classics in chemical neuroscience: Morphine","volume":"9","author":"Devereaux","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"ref_120","unstructured":"(2020, December 29). TG. Principles of Nonsteroidal Anti-Inflammatory Drug Use for Musculoskeletal Conditions in Adults. In eTG Complete Melbourne: Therapeutic Guidelines Limited. Available online: https:\/\/tgldcdp.tg.org.au\/index."},{"key":"ref_121","unstructured":"CDC (2020, December 29). Prescription Opioids: Side Effects. Centers for Disease Control and Prevention, Available online: https:\/\/www.cdc.gov\/drugoverdose\/opioids\/prescribed.html."},{"key":"ref_122","unstructured":"WHO (2021, October 26). Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence. World Health Organization, Geneva. Available online: http:\/\/apps.who.int\/iris\/bitstream\/10665\/43948\/1\/9789241547543_eng.pdf."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0304-3959(93)90007-C","article-title":"Is disease progression the major factor in morphine \u2018tolerance\u2019 in cancer pain treatment?","volume":"55","author":"Collin","year":"1993","journal-title":"Pain"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1533-2500.2007.00119.x","article-title":"Opioid rotation from high-dose morphine to transdermal buprenorphine (Transtec\u00ae) in chronic pain patients","volume":"7","author":"Freye","year":"2007","journal-title":"Pain Pract."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1089\/jpm.2013.0222","article-title":"Methadone rotation for cancer patients with refractory pain in a palliative care unit: An observational study","volume":"16","author":"Rhondali","year":"2013","journal-title":"J. Palliat. Med."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.2147\/OTT.S91347","article-title":"Long-term administration of high doses of transdermal buprenorphine in cancer patients with severe neuropathic pain","volume":"8","author":"Leppert","year":"2015","journal-title":"OncoTargets Ther."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3109\/15360288.2015.1035832","article-title":"Fentanyl Tolerance in the Treatment of Cancer Pain: A Case of Successful Opioid Switching from Fentanyl to Oxycodone at a Reduced Equivalent Dose","volume":"29","author":"Sutou","year":"2015","journal-title":"J. Pain Palliat. Care Pharmacother."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00520-014-2415-9","article-title":"Use of non-opioid analgesics as adjuvants to opioid analgesia for cancer pain management in an inpatient palliative unit: Does this improve pain control and reduce opioid requirements?","volume":"23","author":"Shinde","year":"2014","journal-title":"Support. Care Cancer"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/papr.12045","article-title":"Pregabalin Vs. Opioids for the treatment of neuropathic cancer pain: A prospective, head-to-head, randomized, open-label study","volume":"14","author":"Raptis","year":"2013","journal-title":"Pain Pract."},{"key":"ref_130","first-page":"299","article-title":"Selective blockage of delta opioid receptors prevents the development of morphine tolerance and dependence in mice","volume":"258","author":"Abdelhamid","year":"1991","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0014-2999(95)00554-X","article-title":"Attenuation of morphine tolerance and dependence with the highly selective delta-opioid receptor antagonist TIPP[psi]","volume":"286","author":"Fundytus","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"ref_132","first-page":"1350","article-title":"Differential effects of naltrindole on morphine-induced tolerance and physical dependence in rats","volume":"281","author":"Hepburn","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1523\/JNEUROSCI.0332-05.2005","article-title":"In vivo activation of a mutant-opioid receptor by naltrexone produces a potent analgesic effect but no tolerance: Role of-Receptor activation and-receptor blockade in morphine tolerance","volume":"25","author":"Roy","year":"2005","journal-title":"J. Neurosci."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.neuropharm.2017.12.032","article-title":"Progress in understanding mechanisms of opioid-induced gastrointestinal adverse effects and respiratory depression","volume":"131","author":"Imam","year":"2018","journal-title":"Neuropharmacology"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1744-8069-3-37","article-title":"Trafficking of central opioid receptors and descending pain inhibition","volume":"3","author":"Bie","year":"2007","journal-title":"Mol. Pain"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/ana.22002","article-title":"How to design an opioid drug that causes reduced tolerance and dependence","volume":"67","author":"Bs","year":"2010","journal-title":"Ann. Neurol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.jpain.2017.04.001","article-title":"OPRM1 methylation contributes to opioid tolerance in cancer patients","volume":"18","author":"Viet","year":"2017","journal-title":"J. Pain"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"31731","DOI":"10.1074\/jbc.M111.248310","article-title":"Agonist-directed Interactions with Specific \u03b2-Arrestins Determine \u03bc-Opioid Receptor Trafficking, Ubiquitination, and Dephosphorylation","volume":"286","author":"Groer","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"e34989","DOI":"10.7554\/eLife.34989","article-title":"Cellular tolerance at the \u00b5-opioid receptor is phosphorylation dependent","volume":"7","author":"Arttamangkul","year":"2018","journal-title":"eLife"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.conb.2007.10.004","article-title":"The role of mu opioid receptor desensitization and endocytosis in morphine tolerance and dependence","volume":"17","author":"Martini","year":"2007","journal-title":"Curr. Opin. Neurobiol."},{"key":"ref_141","first-page":"260","article-title":"Long-term adaptation to high doses of morphine causes desensitization of mu-OR- and delta-OR-stimulated G-protein response in forebrain cortex but does not decrease the amount of G-protein alpha subunits","volume":"16","author":"Bourova","year":"2010","journal-title":"Med. Sci. Monit."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"ra54","DOI":"10.1126\/scisignal.2000807","article-title":"Increased abundance of opioid receptor heteromers following chronic morphine administration","volume":"3","author":"Gupta","year":"2010","journal-title":"Sci. Signal."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s11064-015-1638-6","article-title":"Chronic morphine reduces surface expression of \u03b4-Opioid receptors in subregions of rostral striatum","volume":"41","author":"Leah","year":"2015","journal-title":"Neurochem. Res."},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Paul, A., Gueven, N., and Dietis, N. (2021). Profiling the effects of repetitive morphine administration on motor behavior in rats. Molecules, 26.","DOI":"10.3390\/molecules26144355"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.neuropharm.2017.04.034","article-title":"Morphine dosing strategy plays a key role in the generation and duration of the produced antinociceptive tolerance","volume":"121","author":"Paul","year":"2017","journal-title":"Neuropharmacology"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/978-3-7091-6975-9_7","article-title":"Central analgesics","volume":"38","author":"McQuay","year":"1987","journal-title":"Acta Neurochir. Suppl."},{"key":"ref_147","first-page":"597","article-title":"Animal models of nociception","volume":"53","author":"Gozariu","year":"2001","journal-title":"Pharmacol. Rev."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1600-0773.1998.tb01478.x","article-title":"Aspects on Tail-Flick, Hot-Plate and electrical stimulation tests for morphine antinociception","volume":"83","year":"1998","journal-title":"Pharmacol. Toxicol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2165\/11630080-000000000-00000","article-title":"Adverse effects associated with non-opioid and opioid treatment in patients with chronic pain","volume":"32","author":"Labianca","year":"2012","journal-title":"Clin. Drug Investig."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s13181-012-0269-4","article-title":"Dependence and addiction during chronic opioid therapy","volume":"8","author":"Juurlink","year":"2012","journal-title":"J. Med. Toxicol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.pain.2007.03.028","article-title":"Opioid dependence and addiction during opioid treatment of chronic pain","volume":"129","author":"Ballantyne","year":"2007","journal-title":"Pain"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1126\/science.278.5335.58","article-title":"Molecular and Cellular Basis of Addiction","volume":"278","author":"Nestler","year":"1997","journal-title":"Science"},{"key":"ref_153","unstructured":"Mai, J.K., and Paxinos, G. (2012). Chapter 12-Locus coeruleus. The Human Nervous System, Academic Press. [3rd ed.]."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1151\/spp021113","article-title":"The neurobiology of opioid dependence: Implications for treatment","volume":"1","author":"Kosten","year":"2002","journal-title":"Sci. Pract. Perspect."},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"Listos, J., \u0141upina, M., Talarek, S., Mazur, A., Orzelska-G\u00f3rka, J., and Kotli\u0144ska, J. (2019). The mechanisms involved in morphine addiction: An overview. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20174302"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC Guideline for prescribing opioids for chronic pain\u2014United States, 2016","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA"},{"key":"ref_157","unstructured":"(PHE) Public Health England, Faculty of Medicine of the Royal College of Anaesthetists, Royal College of General Practitioners, and The British Pain Society (2016, September 24). Managing Persistent Pain in Secure Settings, Available online: http:\/\/www.nta.nhs.uk\/uploads\/persistentpain.pdf."},{"key":"ref_158","unstructured":"NOUGG (2016, September 24). Canadian Guideline for Safe and Effective Use of Opioids for Chronic Non-Cancer Pain. Canada. National Opioid Use Guideline Group (NOUGG). Available online: http:\/\/nationalpaincentre.mcmaster.ca\/opioid\/."},{"key":"ref_159","doi-asserted-by":"crossref","unstructured":"American Society of Anesthesiologists Task Force on Chronic Pain Management (2010). American Society of Regional Anesthesia and Pain Medicine Practice Guidelines for Chronic Pain Management. Anesthesiology, 112, 810\u2013833.","DOI":"10.1097\/ALN.0b013e3181c43103"},{"key":"ref_160","first-page":"S5","article-title":"Opioids in the management of chronic non-cancer pain: An update of American Society of the Interventional Pain Physicians\u2019 (ASIPP) Guidelines","volume":"11","author":"Trescot","year":"2008","journal-title":"Pain Physician"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"S225","DOI":"10.1016\/j.pmrj.2015.08.016","article-title":"How to maximize patient safety when prescribing opioids","volume":"7","author":"Kirpalani","year":"2015","journal-title":"PM&R"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/ACO.0b013e32833c57a8","article-title":"Opioid use in chronic noncancer pain: Guidelines revisited","volume":"23","author":"Stein","year":"2010","journal-title":"Curr. Opin. Anaesthesiol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1177\/0897190017732263","article-title":"Peripherally acting \u03bc-Opioid receptor antagonists for the treatment of opioid-related side effects: Mechanism of action and clinical implications","volume":"31","author":"Streicher","year":"2017","journal-title":"J. Pharm. Pr."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/ajg.2011.30","article-title":"Opioid-Induced constipation: Challenges and therapeutic opportunities","volume":"106","author":"Camilleri","year":"2011","journal-title":"Am. J. Gastroenterol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/toxsci\/kfv055","article-title":"Morphine-Induced constipation develops with increased aquaporin-3 expression in the colon via increased serotonin secretion","volume":"145","author":"Kon","year":"2015","journal-title":"Toxicol. Sci."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1111\/nmo.12443","article-title":"Site and mechanism of morphine tolerance in the gastrointestinal tract","volume":"26","author":"Akbarali","year":"2014","journal-title":"Neurogastroenterol. Motil."},{"key":"ref_167","first-page":"1347","article-title":"Management of common opioid-induced adverse effects","volume":"74","author":"Swegle","year":"2006","journal-title":"Am. Fam. Physician"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1200\/JCO.2001.19.9.2542","article-title":"For the expert working group of the european association of palliative care network strategies to manage the adverse effects of oral morphine: An evidence-based report","volume":"19","author":"Cherny","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.12968\/bjon.2016.25.10.S4","article-title":"Management of opioid-induced constipation","volume":"25","author":"Prichard","year":"2016","journal-title":"Br. J. Nurs."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0304-3959(99)00185-2","article-title":"Oral naloxone reverses opioid-associated constipation","volume":"84","author":"Meissner","year":"2000","journal-title":"Pain"},{"key":"ref_171","first-page":"822","article-title":"Treatment of constipation in chronic pain patients","volume":"62","author":"Shimoyama","year":"2013","journal-title":"Masui. Jpn. J. Anesthesiol."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s40265-014-0177-9","article-title":"Oxycodone\/naloxone prolonged-release: A review of its use in the management of chronic pain while counteracting opioid-induced constipation","volume":"74","author":"Burness","year":"2014","journal-title":"Drugs"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"R1046","DOI":"10.1186\/ar1782","article-title":"Prevalence of opioid adverse events in chronic non-malignant pain: Systematic review of randomised trials of oral opioids","volume":"7","author":"Moore","year":"2005","journal-title":"Arthritis Res."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/00000542-199207000-00023","article-title":"Postoperative nausea and vomiting. Its etiology, treatment, and prevention","volume":"77","author":"Watcha","year":"1992","journal-title":"Anesthesiology"},{"key":"ref_175","doi-asserted-by":"crossref","unstructured":"Lehnen, N., Heuser, F., Saglam, M., Schulz, C.M., Wagner, K.J., Taki, M., Kochs, E.F., Jahn, K., Brandt, T., and Glasauer, S. (2015). Opioid-inducednausea involves a vestibular problem preventable by head-rest. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0135263"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.ctrv.2015.09.005","article-title":"Mechanisms and latest clinical studies of new NK1 receptor antagonists for chemotherapy-induced nausea and vomiting: Rolapitant and NEPA (netupitant\/palonosetron)","volume":"41","author":"Rojas","year":"2015","journal-title":"Cancer Treat. Rev."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejphar.2013.08.049","article-title":"Molecular mechanisms of 5-HT3 and NK1 receptor antagonists in prevention of emesis","volume":"722","author":"Rojas","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"ref_178","doi-asserted-by":"crossref","unstructured":"Koju, R.B., Gurung, B.S., and Dongol, Y. (2015). Prophylactic administration of ondansetron in prevention of intrathecal morphine-induced pruritus and post-operative nausea and vomiting in patients undergoing caesarean section. BMC Anesthesiol., 15.","DOI":"10.1186\/1471-2253-15-18"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"68","DOI":"10.5694\/j.1326-5377.1999.tb126885.x","article-title":"Opioid substitution to reduce adverse effects in cancer pain management","volume":"170","author":"Ashby","year":"1999","journal-title":"Med. J. Aust."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/0885-3924(95)90924-C","article-title":"Opioid rotation for toxicity reduction in terminal cancer patients","volume":"10","author":"Bruera","year":"1995","journal-title":"J. Pain Symptom Manag."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.2165\/11596250-000000000-00000","article-title":"Neuraxial morphine and respiratory depression","volume":"71","author":"Sultan","year":"2011","journal-title":"Drugs"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/bph.12696","article-title":"In vivo profiling of seven common opioids for antinociception, constipation and respiratory depression: No two opioids have the same profile","volume":"172","author":"Kuo","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"5994","DOI":"10.2174\/138161212803582469","article-title":"Non-analgesic effects of opioids: Opioid-induced respiratory depression","volume":"18","author":"Boom","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.neuroscience.2010.11.012","article-title":"Effect of chronic pain on morphine-induced respiratory depression in mice","volume":"174","author":"Kamei","year":"2011","journal-title":"Neuroscience"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/bph.14860","article-title":"Fentanyl depression of respiration: Comparison with heroin and morphine","volume":"177","author":"Hill","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1126\/science.1084674","article-title":"5-HT 4(a) Receptors avert opioid-induced breathing depression without loss of analgesia","volume":"301","author":"Manzke","year":"2003","journal-title":"Science"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/bja\/aen094","article-title":"Opioids and the control of respiration","volume":"100","author":"Pattinson","year":"2008","journal-title":"Br. J. Anaesth."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s00482-011-1044-1","article-title":"Die von serotoninrezeptor 1A modulierte dephosphorylierung des glyzinrezeptors \u03b13","volume":"25","author":"Manzke","year":"2011","journal-title":"Der. Schmerz"},{"key":"ref_189","first-page":"36","article-title":"Finding an optimal dose: Considerations in accurate opioid dispensing","volume":"42","author":"Dunn","year":"2000","journal-title":"Vet. Hum. Toxicol."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0014-2999(02)01715-6","article-title":"Naloxone methiodide reverses opioid-induced respiratory depression and analgesia without withdrawal","volume":"445","author":"Lewanowitsch","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1111\/bcp.12008","article-title":"Analgesia and central side-effects: Two separate dimensions of morphine response","volume":"75","author":"Droney","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1476-5381.1972.tb06866.x","article-title":"Time-dose relationships for locomotor activity effects of morphine after acute or repeated treatment","volume":"46","author":"Babbini","year":"1972","journal-title":"Br. J. Pharmacol."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/1440-1681.12203","article-title":"Effects of acute and long-term typical or atypical neuroleptics on morphine-induced behavioural effects in mice","volume":"41","author":"Hollais","year":"2014","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.pbb.2005.07.004","article-title":"Behavioral characterization of morphine effects on motor activity in mice","volume":"81","author":"Patti","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0091-3057(00)00207-0","article-title":"Lack of specific effects of selective D1 and D2 dopamine antagonists vs. risperidone on morphine-induced hyperactivity","volume":"66","author":"Broseta","year":"2000","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0024-3205(76)90213-7","article-title":"Mixed depressant and stimulant actions of morphine and their relationship to brain acetylcholine","volume":"18","author":"Domino","year":"1976","journal-title":"Life Sci."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0091-3057(81)90403-2","article-title":"Locomotor activity in morphine-dependent and post-dependent rats","volume":"14","author":"Brady","year":"1981","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/BF00433741","article-title":"The effects of morphine and delta-9-tetrahydrocannabinol on motor activity in rats","volume":"78","author":"Tulunay","year":"1982","journal-title":"Psychopharmacology"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1046\/j.1471-4159.2001.00599.x","article-title":"A comparison of morphine-induced locomotor activity and mesolimbic dopamine release in C57BL6, 129Sv and DBA2 mice","volume":"79","author":"Murphy","year":"2008","journal-title":"J. Neurochem."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1476-5381.1971.tb07195.x","article-title":"Turning behaviour as an index of the action of amphetamines and ephedrines on central dopamine-containing neurones","volume":"43","author":"Christie","year":"1971","journal-title":"Br. J. Pharmacol."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0031-9384(73)90134-0","article-title":"An automatic apparatus for recording rotational behaviour in rats with brain lesions","volume":"11","author":"Barber","year":"1973","journal-title":"Physiol. Behav."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/npp.2010.186","article-title":"A Dopamine D1 receptor-dependent \u03b2-arrestin signaling complex potentially regulates morphine-induced psychomotor activation but not reward in mice","volume":"36","author":"Urs","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3389\/fnins.2017.00295","article-title":"Dopamine and the brainstem locomotor networks: From lamprey to human","volume":"11","author":"Ryczko","year":"2017","journal-title":"Front. Neurosci."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.bbr.2014.11.014","article-title":"Striatal dopamine receptor plasticity in neurotensin deficient mice","volume":"280","author":"Chastain","year":"2014","journal-title":"Behav. Brain Res."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1038\/sj.npp.1301321","article-title":"Activation of the cAMP\/PKA\/DARPP-32 signaling pathway is required for morphine psychomotor stimulation but not for morphine reward","volume":"32","author":"Borgkvist","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"1179069518779829","DOI":"10.1177\/1179069518779829","article-title":"Physiological and functional basis of dopamine receptors and their role in neurogenesis: Possible implication for Parkinson\u2019s disease","volume":"12","author":"Mishra","year":"2018","journal-title":"J. Exp. Neurosci."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/bcpt.12655","article-title":"The pharmacology and toxicology of the \u2018Holy Trinity\u2019","volume":"120","author":"Horsfall","year":"2016","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"ref_208","doi-asserted-by":"crossref","unstructured":"Torregrossa, M. (2019). Chapter 4-Neural circuit plasticity in addiction. Neural Mechanisms of Addiction, Academic Press.","DOI":"10.1016\/B978-0-12-812202-0.00001-4"},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3389\/fpsyt.2016.00030","article-title":"Ventral tegmental area afferents and drug-dependent behaviors","volume":"7","author":"Oliva","year":"2016","journal-title":"Front. Psychiatry"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/10673220490910844","article-title":"Neurobiologic processes in drug reward and addiction","volume":"12","author":"Adinoff","year":"2004","journal-title":"Harv. Rev. Psychiatry"},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0149-7634(99)00048-2","article-title":"Heterogeneity of the mesotelencephalic dopamine fibers: Physiology and pharmacology","volume":"24","author":"Gardner","year":"2000","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1515\/REVNEURO.2006.17.1-2.111","article-title":"Rearing on hind legs, environmental novelty, and the hippocampal formation","volume":"17","author":"Lever","year":"2006","journal-title":"Rev. Neurosci."},{"key":"ref_213","unstructured":"Levin, E.D., and Buccafusco, J.J. (2006). Frontiers in neuroscience assessments of cognitive deficits in mutant mice. Animal Models of Cognitive Impairment, CRC Press\/Taylor & Francis, Taylor & Francis Group, LLC."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"315","DOI":"10.4236\/jbbs.2012.23036","article-title":"High-and Low-Rearing rats differ in the brain excitability controlled by the allosteric benzodiazepine site in the GABAA receptor","volume":"2","author":"Alves","year":"2012","journal-title":"J. Behav. Brain Sci."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/sj.npp.1300416","article-title":"Modulation of anxiety-like behavior and morphine dependence in CREB-deficient mice","volume":"29","author":"Valverde","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"ref_216","first-page":"475","article-title":"Morphine-induced analgesic tolerance, locomotor sensitization and physical dependence do not require modification of mu opioid receptor, cdk5 and adenylate cyclase activity","volume":"54","author":"Contet","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.bbr.2015.05.053","article-title":"Antagonism of \u03ba opioid receptor in the nucleus accumbens prevents the depressive-like behaviors following prolonged morphine abstinence","volume":"291","author":"Zan","year":"2015","journal-title":"Behav. Brain Res."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1089\/neu.2016.4601","article-title":"Nor-binaltorphimine blocks the adverse effects of morphine after spinal cord injury","volume":"34","author":"Aceves","year":"2017","journal-title":"J. Neurotrauma"},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1037\/0033-2909.83.3.482","article-title":"The open-field test: A critical review","volume":"83","author":"Walsh","year":"1976","journal-title":"Psychol. Bull."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.pbb.2018.03.003","article-title":"Age-dependent antinociception and behavioral inhibition by morphine","volume":"168","author":"Paul","year":"2018","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.dib.2018.05.001","article-title":"Data on prolonged morphine-induced antinociception and behavioral inhibition in older rats","volume":"19","author":"Paul","year":"2018","journal-title":"Data Brief."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/ACO.0b013e328360b086","article-title":"Prophylaxis and treatment of the side-effects of neuraxial morphine analgesia following cesarean delivery","volume":"26","author":"Dominguez","year":"2013","journal-title":"Curr. Opin. Anaesthesiol."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1017\/S026502150600038X","article-title":"Opioid-related side-effects after intrathecal morphine","volume":"23","author":"Raffaeli","year":"2006","journal-title":"Eur. J. Anaesthesiol."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.36076\/ppj.2008\/11\/S105","article-title":"Opioid complications and side effects","volume":"11","author":"Benyamin","year":"2008","journal-title":"Pain Physician"},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.cell.2011.09.026","article-title":"Why does morphine make you itch?","volume":"147","author":"Miyamoto","year":"2011","journal-title":"Cell"},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.cell.2011.08.043","article-title":"Unidirectional cross-activation of GRPR by MOR1D uncouples itch and analgesia induced by opioids","volume":"147","author":"Liu","year":"2011","journal-title":"Cell"},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3109\/01480545.2014.922095","article-title":"Withdrawal of repeated morphine enhances histamine-induced scratching responses in mice","volume":"38","author":"Abe","year":"2015","journal-title":"Drug Chem. Toxicol."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.neuroscience.2016.06.029","article-title":"Opioid-induced hyperalgesia: Cellular and molecular mechanisms","volume":"338","author":"Roeckel","year":"2016","journal-title":"Neuroscience"},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.2119\/molmed.2012.00244","article-title":"Morphine induces hyperalgesia without involvement of \u00b5-Opioid receptor or morphine-3-glucuronide","volume":"18","author":"Swartjes","year":"2012","journal-title":"Mol. Med."},{"key":"ref_230","doi-asserted-by":"crossref","unstructured":"Song, L., Wu, C., and Zuo, Y. (2015). Melatonin prevents morphine-induced hyperalgesia and tolerance in rats: Role of protein kinase C and N-methyl-D-aspartate receptors. BMC Anesthesiol., 15.","DOI":"10.1186\/1471-2253-15-12"},{"key":"ref_231","first-page":"e51264","article-title":"Assessment of morphine-induced hyperalgesia and analgesic tolerance in mice using thermal and mechanical nociceptive modalities","volume":"89","author":"Elhabazi","year":"2014","journal-title":"J. Vis. Exp."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.coph.2009.09.007","article-title":"Opioid-receptor-heteromer-specific trafficking and pharmacology","volume":"10","author":"Whistler","year":"2010","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1124\/mol.109.055913","article-title":"\u03b4 Receptors are required for full inhibitory coupling of \u03bc receptors to voltage-dependent Ca2+ channels in dorsal root ganglion neurons","volume":"76","author":"Walwyn","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"ref_234","first-page":"3594","article-title":"Modulation of opioid receptor function by protein-protein interactions","volume":"14","author":"Gomes","year":"2009","journal-title":"Front. Biosci."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"668","DOI":"10.2174\/092986608785133672","article-title":"Multiple ligands in opioid research","volume":"15","author":"Ballet","year":"2008","journal-title":"Protein Pept. Lett."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"312","DOI":"10.2174\/157016308786733591","article-title":"Bivalent ligands as specific pharmacological tools for G protein-coupled receptor dimers","volume":"5","author":"Lezoualc","year":"2008","journal-title":"Curr. Drug Discov. Technol."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.brainres.2006.01.095","article-title":"Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors","volume":"1083","author":"Yamada","year":"2006","journal-title":"Brain Res."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/sj.bjp.0707277","article-title":"Augmentation of spinal morphine analgesia and inhibition of tolerance by low doses of \u03bc- and \u03b4 -opioid receptor antagonists","volume":"151","author":"Sutak","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejphar.2006.12.013","article-title":"Inhibition of tolerance to spinal morphine antinociception by low doses of opioid receptor antagonists","volume":"560","author":"McNaull","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/bja\/aep129","article-title":"Simultaneous targeting of multiple opioid receptors: A strategy to improve side-effect profile","volume":"103","author":"Dietis","year":"2009","journal-title":"Br. J. Anaesth."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"6523","DOI":"10.1021\/jm058225d","article-title":"Designed multiple ligands. An emerging drug discovery paradigm","volume":"48","author":"Morphy","year":"2005","journal-title":"J. Med. Chem."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.lfs.2009.02.025","article-title":"Bi- or multifunctional opioid peptide drugs","volume":"86","author":"Schiller","year":"2010","journal-title":"Life Sci."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1124\/jpet.109.157446","article-title":"Comparison of the antinociceptive and antirewarding profiles of novel bifunctional nociceptin receptor\/\u03bc-opioid receptor ligands: Implications for therapeutic applications","volume":"331","author":"Toll","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ejmech.2015.11.028","article-title":"Multitarget opioid ligands in pain relief: New players in an old game","volume":"108","author":"Turnaturi","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"ref_245","first-page":"21","article-title":"Multifunctional opioid ligands","volume":"247","author":"Anand","year":"2018","journal-title":"Gastrointest. Regul. Pept."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.neuropharm.2019.03.006","article-title":"Bifunctional opioid receptor ligands as novel analgesics","volume":"151","author":"Cunningham","year":"2019","journal-title":"Neuropharmacology"},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.peptides.2008.03.022","article-title":"Structure\u2013activity relationships of bifunctional cyclic disulfide peptides based on overlapping pharmacophores at opioid and cholecystokinin receptors","volume":"29","author":"Agnes","year":"2008","journal-title":"Peptides"},{"key":"ref_248","doi-asserted-by":"crossref","unstructured":"Kulkarni, V.V., Lee, Y.S., Salibay, C., Davis, P., Ma, S.-W., Porreca, F., and Hruby, V.J. (2009). Novel analogues of bifunctional ligands for opioid and melanocortin 4 receptor. Peptides for Youth, Springer.","DOI":"10.1007\/978-0-387-73657-0_90"},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"5491","DOI":"10.1021\/jm100157m","article-title":"Biological and conformational evaluation of bifunctional compounds for opioid receptor agonists and neurokinin 1 receptor antagonists possessing two penicillamines","volume":"53","author":"Yamamoto","year":"2010","journal-title":"J. Med. Chem."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1021\/cb400113d","article-title":"An immunocytochemical-derived correlate for evaluating the bridging of heteromeric mu-delta opioid protomers by bivalent ligands","volume":"8","author":"Yekkirala","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1097\/j.pain.0000000000001262","article-title":"A bifunctional-biased mu-opioid agonist\u2013neuropeptide FF receptor antagonist as analgesic with improved acute and chronic side effects","volume":"159","author":"Guillemyn","year":"2018","journal-title":"Pain"},{"key":"ref_252","first-page":"367","article-title":"Cebranopadol: A novel first-in-class potent analgesic acting via NOP and opioid receptors","volume":"254","author":"Tzschentke","year":"2019","journal-title":"Antisense Res. Appl."},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/bph.12663","article-title":"Heteromers of \u03bc-\u03b4 opioid receptors: New pharmacology and novel therapeutic possibilities","volume":"172","author":"Fujita","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"RC110","DOI":"10.1523\/JNEUROSCI.20-22-j0007.2000","article-title":"Heterodimerization of mu and delta opioid receptors: A role in opiate synergy","volume":"20","author":"Gomes","year":"2000","journal-title":"J. Neurosci."},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.1111\/bph.12798","article-title":"Revolution in GPCR signalling: Opioid receptor heteromers as novel therapeutic targets: IUPHAR Review 10","volume":"171","author":"Fujita","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"12072","DOI":"10.1073\/pnas.1222044110","article-title":"Identification of a-opioid receptor heteromer-biased agonist with antinociceptive activity","volume":"110","author":"Gomes","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_257","doi-asserted-by":"crossref","unstructured":"Milan-Lobo, L., Enquist, J., Van Rijn, R.M., and Whistler, J.L. (2013). Anti-analgesic effect of the mu\/delta opioid receptor heteromer revealed by ligand-biased antagonism. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0058362"},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1526-4637.2007.00355.x","article-title":"Phase II, Open-label, multicenter study of combined intrathecal morphine and ziconotide: Addition of ziconotide in patients receiving intrathecal morphine for severe chronic pain","volume":"9","author":"Wallace","year":"2008","journal-title":"Pain Med."},{"key":"ref_259","unstructured":"Krames, E.S., Peckham, P.H., and Rezai, A.R. (2009). Chapter 35-Intrathecal non-opioid analgesics for the control of pain. Neuromodulation, Academic Press."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/14\/11\/1091\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:21:34Z","timestamp":1760167294000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/14\/11\/1091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,27]]},"references-count":259,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,11]]}},"alternative-id":["ph14111091"],"URL":"https:\/\/doi.org\/10.3390\/ph14111091","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,27]]}}}